American Family Children's Hospital
SHARE TEXT
David R. Andes, MD close
Tvg6uXVvHQc
David R. Andes, MD
 


For Patients

Need help selecting a doctor?
Call the Welcome Center at
(608) 821-4819 for personal assistance.

For Referring Physicians

How to refer a patient

David R. Andes, MD Print Friendly Page

Faculty, University of Wisconsin School of Medicine and Public Health

Dr. Andes’ clinical interests include general infectious diseases, transplant infectious diseases, mycology, antimicrobial pharmacokinetics and pharmacodynamics. 

Specialties

Infectious Diseases

Travel Medicine

UW Health Clinics

Infectious Disease Clinic
University Hospital
(608) 263-0946 | (800) 323-8942 | Map
Travel Medicine
University Hospital
(608) 890-6167 | (800) 323-8942 | Map

Hospital Affiliation(s)

University Hospital (primary)
Veterans Hospital - Wm. S. Middleton Memorial, UnityPoint Health - Meriter (secondary)

UW School of Medicine and Public Health

Department of Medicine

Professional Certifications and Education

Board Certification Infectious Diseases
Fellowship University of Wisconsin Hospital and Clinics, Madison, WI
Residency University of Wisconsin Hospital and Clinics, Madison, WI
Internship University of Wisconsin Hospital and Clinics, Madison, WI
Medical School University of Missouri, 1992

Awards/Honors

Best Doctors® in America 2015

Best Doctors® in America 2014

Best Doctors® in America 2013

Madison Magazine Top Docs 2012

 


Medical interpreters are available to help patients communicate with hospital and clinic staff. For more information, please contact interpreter services at (608) 262-9000.
Research

The overriding themes of our research programs are to advance our understanding of antibacterial and antifungal activity and drug resistance, and to identify new antimicrobial drug treatment strategies and drug targets.


PubMed Articles
Pappas PG Kauffman CA Andes DR Clancy CJ Marr KA Ostrosky-Zeichner L Reboli AC Schuster MG Vazquez JA Walsh TJ Zaoutis TE Sobel JD . Executive Summary: Clinical Practice Guideline for the Management of Candidiasis: 2016 Update by the Infectious Diseases Society of America. Clin Infect Dis. 2016 Feb 15;62(4):409-17
[PubMed ID: 26810419]
Pappas PG Kauffman CA Andes DR Clancy CJ Marr KA Ostrosky-Zeichner L Reboli AC Schuster MG Vazquez JA Walsh TJ Zaoutis TE Sobel JD . Clinical Practice Guideline for the Management of Candidiasis: 2016 Update by the Infectious Diseases Society of America. Clin Infect Dis. 2016 Feb 15;62(4):e1-e50
[PubMed ID: 26679628]
Raman N Marchillo K Lee MR Rodríguez López AL Andes DR Palecek SP Lynn DM . Intraluminal Release of an Antifungal β-Peptide Enhances the Antifungal and Anti-Biofilm Activities of Multilayer-Coated Catheters in a Rat Model of Venous Catheter Infection. ACS Biomater Sci Eng. 2016 Jan 11;2(1):112-121
[PubMed ID: 26807439]
Nett JE Andes DR . Antifungal Agents: Spectrum of Activity, Pharmacology, and Clinical Indications. Infect Dis Clin North Am. 2015 Dec 28;
[PubMed ID: 26739608]
Walsh TJ Azie N Andes DR . Development of New Strategies for Echinocandins: Progress in Translational Research. Clin Infect Dis. 2015 Dec 1;61 Suppl 6:S601-3
[PubMed ID: 26567276]
Nett JE Zarnowski R Cabezas-Olcoz J Brooks EG Bernhardt J Marchillo K Mosher DF Andes DR . Host Contributions to Construction of Three Device-Associated Candida albicans Biofilms. Infect Immun. 2015 Dec;83(12):4630-8
[PubMed ID: 26371129]
Sidoryk K Świtalska M Jaromin A Cmoch P Bujak I Kaczmarska M Wietrzyk J Dominguez EG Żarnowski R Andes DR Bańkowski K Cybulski M Kaczmarek Ł . The synthesis of indolo[2,3-b]quinoline derivatives with a guanidine group: highly selective cytotoxic agents. Eur J Med Chem. 2015 Nov 13;105:208-19
[PubMed ID: 26496013]
Lepak AJ Parhi A Madison M Marchillo K VanHecker J Andes DR . In Vivo Pharmacodynamic Evaluation of an FtsZ Inhibitor, TXA-709, and Its Active Metabolite, TXA-707, in a Murine Neutropenic Thigh Infection Model. Antimicrob Agents Chemother. 2015 Oct;59(10):6568-74
[PubMed ID: 26259789]
Zhang F Adnani N Vazquez-Rivera E Braun DR Tonelli M Andes DR Bugni TS . Application of 3D NMR for Structure Determination of Peptide Natural Products. J Org Chem. 2015 Sep 4;80(17):8713-9
[PubMed ID: 26273993]
Vergidis P Avery RK Wheat LJ Dotson JL Assi MA Antoun SA Hamoud KA Burdette SD Freifeld AG McKinsey DS Money ME Myint T Andes DR Hoey CA Kaul DA Dickter JK Liebers DE Miller RA Muth WE Prakash V Steiner FT Walker RC Hage CA . Histoplasmosis complicating tumor necrosis factor-α blocker therapy: a retrospective analysis of 98 cases. Clin Infect Dis. 2015 Aug 1;61(3):409-17
[PubMed ID: 25870331]
Verweij PE Ananda-Rajah M Andes D Arendrup MC Brüggemann RJ Chowdhary A Cornely OA Denning DW Groll AH Izumikawa K Kullberg BJ Lagrou K Maertens J Meis JF Newton P Page I Seyedmousavi S Sheppard DC Viscoli C Warris A Donnelly JP . International expert opinion on the management of infection caused by azole-resistant Aspergillus fumigatus. Drug Resist Updat. 2015 Jul-Aug;21-22:30-40
[PubMed ID: 26282594]
Davis SA Vincent BM Endo MM Whitesell L Marchillo K Andes DR Lindquist S Burke MD . Nontoxic antimicrobials that evade drug resistance. Nat Chem Biol. 2015 Jul;11(7):481-7
[PubMed ID: 26030729]
McCarty TP Baddley JW Walsh TJ Alexander BD Kontoyiannis DP Perl TM Walker R Patterson TF Schuster MG Lyon GM Wingard JR Andes DR Park BJ Brandt ME Pappas PG . Phaeohyphomycosis in transplant recipients: Results from the Transplant Associated Infection Surveillance Network (TRANSNET). Med Mycol. 2015 Jun;53(5):440-6
[PubMed ID: 25908651]
Fox EP Bui CK Nett JE Hartooni N Mui MC Andes DR Nobile CJ Johnson AD . An expanded regulatory network temporally controls Candida albicans biofilm formation. Mol Microbiol. 2015 Jun;96(6):1226-39
[PubMed ID: 25784162]
Mitchell KF Zarnowski R Sanchez H Edward JA Reinicke EL Nett JE Mitchell AP Andes DR . Community participation in biofilm matrix assembly and function. Proc Natl Acad Sci U S A. 2015 Mar 31;112(13):4092-7
[PubMed ID: 25770218]
Lepak AJ Marchillo K Andes DR . Pharmacodynamic target evaluation of a novel oral glucan synthase inhibitor, SCY-078 (MK-3118), using an in vivo murine invasive candidiasis model. Antimicrob Agents Chemother. 2015 Feb;59(2):1265-72
[PubMed ID: 25512406]
Lepak AJ Marchillo K Craig WA Andes DR . In vivo pharmacokinetics and pharmacodynamics of the lantibiotic NAI-107 in a neutropenic murine thigh infection model. Antimicrob Agents Chemother. 2015 Feb;59(2):1258-64
[PubMed ID: 25512404]
Theuretzbacher U Ambrose PG MacGowan AP Andes DR Sörgel F Derendorf H Mouton JW Drusano GL Tulkens PM Dudley MN Cars O Nation RL . In memoriam: William A. Craig. Antimicrob Agents Chemother. 2015;59(6):2971
[PubMed ID: 25896702]
Nett JE Brooks EG Cabezas-Olcoz J Sanchez H Zarnowski R Marchillo K Andes DR . Rat indwelling urinary catheter model of Candida albicans biofilm infection. Infect Immun. 2014 Dec;82(12):4931-40
[PubMed ID: 25183731]
Lepak AJ Andes DR . Antifungal pharmacokinetics and pharmacodynamics. Cold Spring Harb Perspect Med. 2014 Nov 10;5(5):a019653
[PubMed ID: 25384765]